| Bioactivity | Fexapotide (NX-1207 free acid) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research[1][2][3]. |
| Name | Fexapotide |
| CAS | 492447-54-8 |
| Sequence | Ile-Asp-Gln-Gln-Val-Leu-Ser-Arg-Ile-Lys-Leu-Glu-Ile-Lys-Arg-Cys-Leu |
| Shortening | IDQQVLSRIKLEIKRCL |
| Formula | C90H163N27O25S |
| Molar Mass | 2055.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Fexapotide
CAS: 492447-54-8 F: C90H163N27O25S W: 2055.49
Fexapotide (NX-1207 free acid) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide c
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.